FISH analysis for CML monitoring?

Annals of Hematology

Volumn 73, Issue 3, 1996, Pages 113-119

  Cox Froncillo, M C ^a,b   Maffei, L ^a   Cantonetti, M ^a   Del Poeta, G ^a   Lentini, R ^a   Bruno, A ^a   Masi, M ^a   Tribalto, M ^a   Amadori, S ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

BCR ABL; CML monitoring; IFN therapy; Philadelphia chromosome

Indexed keywords

BCR ABL PROTEIN; BUSULFAN; HYDROXYUREA; RECOMBINANT ALPHA2A INTERFERON;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; HUMAN CELL; INTERPHASE; LABORATORY; LEUKEMIA CELL; MALE; METAPHASE; MITOSIS; PATIENT MONITORING; PRIORITY JOURNAL;

CYTOGENETICS; FOLLOW-UP STUDIES; FUSION PROTEINS, BCR-ABL; GENES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERONS; INTERPHASE; LEUKEMIA, MYELOID, CHRONIC;

EID: 0029785977     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050211     Document Type: Article

References (40)

1. Talpaz M, Kantarjian H, McCredie K, Trujillo J, Keating M, Gutterman JU (1986). Hematological remission and cytogenetic improvement induced by recombinant human interferon alfa A in chronic myelogenous leukemia. N Engl J Med 314:1065
2. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU (1991) Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 114:532-538
3. The Italian Coopererative Study Group on Chronic Myeloid Leukemia (1994) N Engl J Med 330:820-825
4. Zhao L, Hagop M, Kantarjian M, Van Oort J, Cork A, Trujillo JM, Liang JC (1993) Detection of residual proliferating cells by fluorescence in situ hybridization in CML patients in complete remission after interferon treatment. Leukemia 7:168-171
5. Verschraegen CF, Talpaz M, Hirsch-Ginsberg CF, Pherwani R, Rios MB, Stass AS, Kantarjian H (1995) Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia-positive chronic myeloid leukemia. Blood 85:2705
6. Cremer T, Lamdegent J, Bruckner A, Scholl FIP, Schardin M, Hager HD, Devilee P, Pearson P, Van der Ploeg M (1989) Detection of chromosome abberrations in the human interphase nucleous by visualisation of specific target DNAs with radioactive and non-radioactive in situ hybridisation techniques: diagnosis of trisomy 18 with LI.84. Hum Genet 74:346-352
7. Cherif D, Bernard O, Berger R (1989) Detection of single copy genes by nonisotopic in situ hybridisation on human chromosomes. Hum Genet 81:358-362
8. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dohner H (1994) Detection of chimeric bcr-abl genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83:1922-1928
9. Arnoldous EJP, Wiegant J, Nordermeer I A, Wessels JW, Beverstock GC, Grosveld GC, van der Ploeg M, Raap AK (1990) Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet 54:108-111
10. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanaryan K, Homge M, Redner A, Gray J, Pinkel D (1990) Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559-250
11. Zhang J, Meltzer P, Jenkins R, Guan X-Y, Trent J (1993) Application of chromosome microdissection probes for elucidation of bcr-abl fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood 81:3365-3371
12. Inazawa J, Nishigaki H, Takahira H, Nishimura J, Horiike S, Taniwaki M, Misawa S, Abe T (1989) Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosome 9 and 22 in Ph-negative chronic myelocytic leukemia. Hum Genet 83:115-118
13. Morris C, Kennedy M, Heisterkamp N, Columbano-Green L, Romeril K, Groffen J, Fitzgerald P (1991) A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype. Genes Chromos Cancer 3:263-271
14. Calabrese G, Palka G, Westbrook CA, Sheer D (1992) Complex translocation involving Ph chromosome in a patient with typical chronic myelogenous lekemia. Cancer Genet Cytogenet 63:52-55
15. Zhong C, Morgan R, Berger CS, Pearce-Birge L, Stone JF, Sandberg AA (1993) Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes. Cancer Genet Cytogenet 70:103-107
16. Amiel A, Yarkoni S, Fejgin M, Nagler A, Manor Y, Lishner M (1993) Clinical detection of bcr/abl in situ hybridization in chronic myelogenous leukemia. Cancer Genet Cytogenet 65:32-34
17. Dewald GW, Schad CR, Christensen ER, Tiede AL, Zinsmeiser AR, Spurbeck JL, Thibodeau SN, Jalal SM (1993) The application of in situ fluorescent hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7-14
18. Cox Froncillo MC, Cantonetti M, Masi M, Lentini R, Giudiceandrea P, Maffei L, Tribalto M, Amadori S, Papa G. (1995) Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon therapy. Cancer Genet Cytogenet 84:15-18
19. Cox Froncillo MC, Cantonetti M, Maffei L, Lentini R, Masi M, Giudiceandrea P, Tribalto M, Papa G, Amadori S (1995) Is conventional cytogenetic analysis an effective approach for monitoring disease in CML patients on IFN therapy? 37th Annual Meeting of the American Society of Hematology, Seattle, Wash
20. Rooney DE, Czepulolkowski BH (1992) Human cytogenetics, a practical approach. IRL Press, Oxford
21. Jonas D, Lubbert M, Kawasaki E, Henke M, Bross KJ, Mertelsmann R, Herrmann F (1992) Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemia. Blood 79:1017-1023
22. Ariad S, Dajee D, Willem P, Bezwoda W (1993) Lack of involvement of T-lymphocytes in the leukaemic population during prolonged chronic phase of Philadelphia-chromosome positive chronic myeloid leukemia. Leukemia Lymphoma 10:217-221
23. Dowding C, Guo AP, Osterholz J, Siczkowski M, Goldman J, Gordon M (1991) Interferon-alfa overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 78:499-505
24. Bhatia R, McGlave PB, Verfaillie CM (1995) Treatment of marrow stroma with interferon-alfa restores normal B1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. J Clin Invest 96:931-939
25. Nicolson NL, Talpaz M, Nicolson GL (1995) Interferon-alfa directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: correlation with IFN-alfa treatment outcome in patients with chronic myelogenous leukemia. Gene 159:105-111
26. Aulitzky WE, Peschel C, Schneller F, Huber C (1995) Biotherapy of chronic myelogenous leukemia. Ann Hematol 70:113-120
27. Allan NC, Richards SM, Shepherd PCA (1995) UK medical research council randomised, multicentre trial of interferon-alfan1 for chronic myeloid leukemia: improved survival irrespective of cytogenetic response. Lancet 345:1392-1397
28. Seong DC, Kantarjian HM, Ro JY, Talpaz M, Xu J, Robinson JR, Deisseroth AB, Champlin RE, Siciliano MJ Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myeloid leukemia during treatment. Blood 86:2343-2349
29. Lion T, Gaiger A, Henn T, Horth E, Haas OA, Geissler K, Gadner H (1995) Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with IFN. Leukemia 8:1353-1360
30. Hochhaus A, Reiter A, Skladnv H, Lin F, Mason PJ, Van Rhee F, Shepherd PCA, Allan NC, Hehlman R, Goldman JM, Cross NCP (1995) Quantification of residual disease in chronic myelogenous leukemia patients on inerferon therapy by competitive polymerase chain reaction. 37th Annual Meeting of the American Society of Hematology, Seattle, Wash
31. Guo JQ, Lian JY, Xian YM; Lee MS, Deisseroth A, Staas SA, Champlin RE, Talpaz M, Wang JYJ, Arlinghaus RB (1994) BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia undergoing therapy. Blood 83:3629-3637
32. Guo JQ, Lian JY, Deisseroth A, Talpaz M, Arlinghaus RB (1995) Comparison studies of quantitative BCR-ABL protein expression and cytogenetic analysis in chronic myelogenous leukemia patients. 37th Annual Meeting of the American Society of Hematology, Seattle, Wash
33. Reiter A, Skladny H, Hochhaus, Schulteis B, Bartram CR, Heimpel H, Hehlmann R (1995) Comparison between cytogenetics and quantitative southern blot analysis for monitoring interferon treatment in CML-patients. 37th Annual Meeting of the American Society of Hematology, Seattle, Wash
34. Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M (1992) Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction. Leukemia 6:754-760
35. Biernaux C, Loos M, Sels G, Huez G, Stryckmans P (1995) Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118-3122
36. Keating A, Wang XH, Laraya P (1994) Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood 83:1744-1749
37. Yoffe G, Blick M, Kantarjian H, Spizer G, Gutterman J, Talpaz M (1987) Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia. Blood 69:961-963
38. Hughes TP, Morgan GJ, Martiat P, Goldman JM (1991) Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 77:874-878
39. Thompson JD, Brodsky I, Yunis J (1992) Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation. Blood 79:pp1629
40. Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcript in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:pp1929